🦊/Investors

BeiGene

Venture capital

Changping · Series A–Series B · 38 people tracked

Find your way into BeiGene

193 people in our graph share verified history with the BeiGene team — schools, employers, funds. One of them is your warm intro.

Seth Lieblichunlockedknows Anthony Hooper · together at Amgen (overlapped)
×8knows the team · via Amgen
×3knows the team · via University of South Africa/Universiteit van Suid-Afrika
Fox Verdict
Sign up to see your fit

Investment thesis

BeiGene (branded as BeOne) is a global biotechnology/pharmaceutical company that develops and commercializes cancer treatments and other medicines, not a venture capital investor.

Source: firm website, verified Aug 16, 2026.

Stage
Series A–Series B
HQ
Changping, CN
Founded
2010
Tracked investments
1

Team · 38 people

from the firm's website
Xiaodong Wang, Ph.D.· Co-Founder, Chairman of the Scientific Advisory Board
Aaron Rosenberg· Chief Financial Officer
Adam Roach· Senior Vice President, Head of Japan and Asia Pacific
Anand Reddi· Global Head of Direct-to-Customer Innovation and Digital Health
Beth Wensley· Senior Vice President, Head of Portfolio & Program Management
Chan Lee· General Counsel
Dany Habr, M.D.· Head of Medical Affairs, North America & International Marketsin
David Schenkein, M.D.· Scientific Advisory Board Member
Eleanor Duff, Ph.D.· Senior Vice President, Head of Corporate Communications
Giancarlo Benelli, M.D.· Senior Vice President, Head of Europe
Graham Hardiman· Global Head of Human Resources
Han Ma, M.D., Ph.D.· Chief Safety Officer & Senior Vice President, Global Patient Safety
Jason Radford· Senior Vice President, Strategic Partnerships
Jaspreet Jaggi, M.D., Ph.D.· Senior Vice President, Clinical Portfolio Strategy
Julie Lepin· Senior Vice President, Chief Regulatory Affairs Officer
Jurij Petrin, M.D.· Senior Vice President, Head of New Market Development
Kimberly Wolf· Senior Vice President, Global Commercial Strategy & Operations
Kyu-Sung Lee, Ph.D.· Senior Vice President, Global Head of Technical Operations & Manufacturing
Lai Wang, Ph.D.· President, Global Head of Research & Development
Marcello Damiani· Chief Technology Officer
Mark Lanasa, M.D., Ph.D.· Senior Vice President, Chief Medical Officer, Solid Tumors
Matt Shaulis· General Manager of North America
Michael H. Schoen· Senior Vice President, Head of Government Affairs and Special Assistant to the CEO
Neal Rosen, M.D., Ph.D.· Scientific Advisory Board Member
Shalini Sharp· Director
Steven Young, Ph.D.· Acting Head of Medicinal Chemistry
Tony Guo, Ph.D.· Senior Vice President, Global Statistics & Data Science
Xiaobin Wu, Ph.D.· President & Chief Operating Officer

What they invest in

from 1 of 1 portfolio companies

Biotech ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Shoreline Biosciences

Frequently asked questions

What stage does BeiGene invest at?
BeiGene invests at the Series A, Series B stages.
What sectors does BeiGene focus on?
BeiGene focuses on Biotech, Healthtech.
Where is BeiGene located?
BeiGene is headquartered in Changping, CN.

Media · Podcasts & interviews

featuring the team

BeiGene CEO John V. Oyler's Welcome Remarks on BeiGene Virtual Congress Site

BeiGene · John V. Oyler

Similar investors

Featured in lists